US SB1327 | 2017-2018 | 115th Congress
Status
Sponsorship: Bipartisan Bill
Status: Introduced on June 8 2017 - 25% progression, died in committee
Action: 2017-06-08 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 8 2017 - 25% progression, died in committee
Action: 2017-06-08 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [PDF]
Summary
SITSA Act Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 This bill amends the Controlled Substances Act to establish a new, sixth schedule of controlled substances—schedule A. A drug or substance in schedule A has a chemical structure that is similar to, and an effect on the body that is similar to or greater than, a controlled substance in schedule I, II, III, IV, or V. The bill adds 13 synthetic fentanyl-related substances to schedule A. It also authorizes, and establishes procedures for, the Drug Enforcement Administration (DEA) to temporarily and permanently place a drug or substance in schedule A. The bill establishes criminal penalties for an individual who imports, exports, manufactures, distributes, or possesses with intent to distribute a schedule A substance. However, it explicitly prohibits criminal and civil penalties solely for possession of a schedule A controlled substance. The bill makes it unlawful to import, export, manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense, a schedule A substance that is not clearly labeled. Finally, it establishes new, separate DEA registration requirements for manufacturers, distributors, and importers and exporters of schedule A substances.
Title
SITSA Act Stop the Importation and Trafficking of Synthetic Analogues Act of 2017
Sponsors
| Sen. Chuck Grassley [R-IA] | Sen. Dianne Feinstein [D-CA] | Sen. Ron Johnson [R-WI] | Sen. Amy Klobuchar [D-MN] |
History
| Date | Chamber | Action |
|---|---|---|
| 2017-06-08 | Senate | Read twice and referred to the Committee on the Judiciary. |
Same As/Similar To
HB5531 (Related) 2018-05-22 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
HR934 (Similar To) 2018-06-13 - Motion to reconsider laid on the table Agreed to without objection.
HB6 (Related) 2018-10-24 - Became Public Law No: 115-271.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.
HB2851 (Related) 2018-06-18 - Received in the Senate and Read twice and referred to the Committee on the Judiciary.
HR934 (Similar To) 2018-06-13 - Motion to reconsider laid on the table Agreed to without objection.
HB6 (Related) 2018-10-24 - Became Public Law No: 115-271.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.
HB2851 (Related) 2018-06-18 - Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Subjects
Crime and law enforcement
Criminal procedure and sentencing
Drug trafficking and controlled substances
Fraud offenses and financial crimes
Licensing and registrations
Medical research
Criminal procedure and sentencing
Drug trafficking and controlled substances
Fraud offenses and financial crimes
Licensing and registrations
Medical research
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/115th-congress/senate-bill/1327/all-info |
| Text | https://www.congress.gov/115/bills/s1327/BILLS-115s1327is.pdf |
